Aphria, one of Canada’s largest cannabis producers, has filed documents with U.S. securities regulators signaling its intent to list its shares on the New York Stock Exchange.
If approved, the Ontario-based company will join a growing list of Canadian cannabis firms turning to the top U.S. exchanges to tap the globe’s largest pool of institutional investors.
Since January, Canopy Growth (NYSE: CGC), Tilray (Nasdaq: TLRY) and Cronos Group (Nasdaq: CRON) have debuted their U.S. listings, with Canopy being the first plant-touching business to list on the Big Board.
Earlier this month, Aurora Cannabis announced its plans to list on the NYSE by the end of October. The company’s stock will trade under the ticker symbol ACB.
Aphria’s filing with the U.S. Securities Exchange Commission landed Wednesday – the same day that Canada marked the historic launch of legal recreational marijuana sales.
In Canada, Aphria trades on the Toronto Stock Exchange under the ticker symbol APH. It also trades on the over-the-counter markets.
Additional details about the timing of the NYSE listing or the expected ticker symbol were not immediately available. Company officials couldn’t be reached for comment.
